Clinical Trials Directory

Trials / Unknown

UnknownNCT01992978

Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis

The Influence of Radiofrequency-assisted Hepatectomy on the Perioperative Outcomes and the Long-term Prognosis of HCC With Cirrhosis:A Prospective Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Southwest Hospital, China · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Surgical resection is the most effective treatment of primary and secondary liver tumors. Technical innovations have mainly focused on minimizing bleeding during transection of the hepatic parenchyma because excessive hemorrhage and the need for blood transfusion are associated with increased postoperative morbidity and mortality. Recently,radiofrequency-assisted(RFA)hepatectomy has developed rapidly and gained widespread acceptance for the treatment of hepatocellular carcinomas(HCC),but its influence on the prognosis of HCC patients,especially for those with cirrhosis,is still controversial. Therefore, we design this prospective clinical trial to explore the effect of RFA hepatectomy versus the conventional hepatectomy on the outcomes of perioperative period and prognosis of HCC patients with cirrhosis.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency-assisted HepatectomyRadiofrequency-assisted resection: separating the tumor from liver by using the probe of radiofrequency to block the arterial and vessels before parenchymal transection.
PROCEDUREConventional HepatectomyHepatectomy was conducted without RF assisted during parenchymal transection. Separating and dissecting the tumor with the routine clamp-crushing technical.

Timeline

Start date
2013-11-01
Primary completion
2017-11-01
Completion
2018-12-01
First posted
2013-11-25
Last updated
2015-11-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01992978. Inclusion in this directory is not an endorsement.